Close Menu

A Separate Pot

Over at Future Pundit, Randall Parker says the scientific community "should be concerned that biomedical research funding is under [the] control of older scientists that younger scientists spend much of their career working for." Because investigators now receive their first independent funding at a later age on average than they did even a decade ago, "they spend their younger years as grad students and (poorly paid) postdocs. This puts their research directions much more under the control of (older) professors who run labs and have grants flowing to them," Parker says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports the US National Institutes of Health is investing in studies of the long-term effects of COVID-19.

The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian.

Taiwan is to launch a pilot program offering genetic testing to cancer patients, the Taipei Times reports.

In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.